Why Globus Medical Stock Is Flying Higher in After-Hours Trading

Core Viewpoint - Globus Medical's preliminary fourth quarter 2025 financial results and fiscal 2026 guidance have positively influenced investor sentiment, leading to a significant increase in share price after hours trading [1][3]. Financial Performance - Globus Medical projects a 25.2% year-over-year sales growth for Q4 2025, estimating revenue of $823.2 million, which exceeds analysts' expectations of $778.3 million [3]. - For fiscal 2026, the company has provided revenue guidance of $3.18 billion to $3.22 billion and diluted adjusted earnings per share (EPS) guidance of $4.30 to $4.40, surpassing the analyst consensus of $4.12 [4]. Market Valuation - Despite the recent increase in share price, Globus Medical's stock is currently valued at 30.2 times trailing earnings, which is a discount compared to its five-year average P/E of 44.5, suggesting potential investment opportunities for those interested in healthcare stocks focused on orthopedic and spinal care [5][6].